INSULIN-LIKE GROWTH FACTOR-1 AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN CHILDREN WITH CONGENITAL AND HEREDITARY DISEASES OF HEPATOBILIARY SYSTEM
https://doi.org/10.15825/1995-1191-2012-1-50-54
Abstract
The research of total and free insulin-like growth factor-1 (IGF-1) in 53 children with with congenital and hereditary diseases of hepatobiliary system was performed before liver transplantation, a month and a year after liver transplantation. Data of our research work revealed reliable decrease of total and free IGF-1 serum concentrations in children with liver cirrhosis and controversy increase of PAPP-A, which regulates IGF-1 bioavailability. In a month after orthotopic liver transplantation the level of both fractions of IGF-1 restored. A year later concentrations of total and free IGF-1, and PAPP-A remained at normal rates. Increase of total and free IGF-1 after liver transplantation may contribute to restoration of endocrine regulation of growth, reparative and anabolic processes, and normal physical development of children.
About the Authors
O.P. Shevchenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
O.M. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
A.V Bougrov
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
Y.E. Lourie
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
I.E. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
D.S. Mnatsakanyan
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
O.E. Gichkun
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
S.V. Gautier
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
References
1. Дедов И.И., Тюльпаков А.Н., Петеркова В.А. Соматотропная недостаточность. М., 1998. 302 с.
2. Готье С.В., Константинов Б.А., Цирульникова О.М. Трансплантация печени: Руководство для врачей. М.: Медицинское информационное агентство, 2008. 248 c.
3. Готье С.В., Цирульникова О.М., Габриэлян Н.И., Лурье Ю.Э. Инфекционные осложнения после трансплантации печени. Инфекции в трансплантологии / Под ред. С.В. Готье. М.–Тверь: Триада, 2010. С. 13–53.
4. Лурье Ю.Э. Инсулиноподобный фактор роста-1 // Лаборатория. 2011. No 4. С. 3–6.
5. Цирульникова О.М., Лурье Ю.Э., Цирульникова И.Е. Особенности иммуносупрессивной терапии у детей. Иммуносупрессивная терапия у детей при трансплантации печени. Иммуносупрессия при трансплантации солидных органов / Под ред. С.В. Готье. М.–Тверь: Триада, 2011. С. 273–337.
6. Шевченко А.О., Слесарева Ю.С., Шевченко О.П. Лабораторная диагностика повреждения атеросклеротической бляшки у больных ишемической болезнью сердца: РАРР-А // Клиническая лабораторная диагностика. 2011. No 5. С. 3–10.
7. Bierbrauer J., Weber-Carstens S. Insulin resistance and protein catabolism in critically ill patients. Anasthesiol Intensivmed Notfallmed Schmerzther. 2011 Apr. Vol. 46 (4). P. 268–274.
8. De Palo E.F., Bassanello M., Lancerin F. et al. GH/IGF system, cirrhosis and liver transplantation // Clin. Chim. Acta. 2001 Aug 1. Vol. 310 (1). P. 31–37.
9. Hunninghake G.W., Doerschug K.C., Nymon A.B. et al. Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis // Am. J. Respir Crit. Med. 2010. Aug 15. Vol. 182 (4). P. 517– 525.
10. Inaba T., Saito H., Inoue T., Han I., Furukawa S., Matsuda T. et al. Growth hormone/insulin-like factor I axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy // J. Hepatol. 1999. Vol. 31. P. 271–276.
11. Kawai M., Harada N., Takeyama H., Okajima K. Neutrophil elastase contributes to the development of ischemia/ reperfusion-induced liver injury by decreasing the production of insulin-like growth factor-I in rats // Transl. Res. 2010 Jun. Vol. 155 (6). P. 294–304.
12. Leung K.C., Ho K.K. Measurement of growth hormone, insulin-like growth factor I and their binding proteins: the clinical aspects // Clin. Chim. Acta. 2001 Nov. Vol. 313 (1–2). P. 119–123.
13. Mukherjee A., Helbert M., Davis J., Shalet S. Immune function in hypopituitarism: time to reconsider? // Clin. Endocrinol (Oxf). 2010 Oct. Vol. 73 (4). P. 425–431.
14. Robbins K., McCabe S., Scheiner T. Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis // Clin. Exp. Immunol. 1994 Feb. Vol. 95 (2). P. 337–342.
15. Clark R., Strasser J., McCabe S. Insulin-like growth factor-1 stimulation of lymphopoiesis // J. Clin. Invest. 1993. Vol. 92 (2). P. 540–548.
16. Stefano J.T., Correa-Giannela M.L., Ribeiro C.M. et al. Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C // World J. Gastroenterol. 2006 Jun 28. Vol. 12 (24). P. 3821–3828.
17. 17. Sukhotnik I., Siplovich L., Michael M. Peptide Growth Factors and Intestinal Adaptation in Short Bowel Syndrome. IMAJ . Vol 5 . March 2003.
18. Van Bilsen K., Driessen G.J., de Paus R.A. et al. Low level IGF-1 and common variable immune deficiency: an unusual combination // Neth. J. Med. 2008 Oct. Vol. 66 (9). P. 368–372.
19. Who Child Growth Standarts: Methods and Development: Length / heigth-for-age, weigth-for-age, weigth-for-length, weigth-for-heigth and body mass index-for-age. Acta Paediatrica Supplement. 2006. Vol. 95. P. 5–101.
20. Wu Y.L., Ye J., Zhang S., Zhong J., Xi R.P. Clinical significance of serum IGF-I, IGF-II, IGFBP3 in liver cirrhosis // World J. Gastroenterol. 2004. Vol. 10. P. 2740–2743.
Review
For citations:
Shevchenko O., Tsirulnikova O., Bougrov A., Lourie Y., Tsirulnikova I., Mnatsakanyan D., Gichkun O., Gautier S. INSULIN-LIKE GROWTH FACTOR-1 AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN CHILDREN WITH CONGENITAL AND HEREDITARY DISEASES OF HEPATOBILIARY SYSTEM. Russian Journal of Transplantology and Artificial Organs. 2012;14(1):50-54. (In Russ.) https://doi.org/10.15825/1995-1191-2012-1-50-54
Views:
953
Email this article 